Johnson & Johnson JNJ
NYSE JNJ
$275.15 -3.32 (-1.19%)
At close: Sep 4, 2026 · 4:00 PM EDT

Johnson & Johnson (JNJ) Long-Term Debt Repayments (2009 - 2024)

Johnson & Johnson's (JNJ) quarterly Long-Term Debt Repayments came in at $1.0 million in Q1 2024, down 99.8% year-over-year from $500.0 million in Q2 2023, and down 99.9% quarter-over-quarter from $1.0 billion in Q4 2023.

Analysis

Johnson & Johnson (JNJ) Long-Term Debt Repayments (2009 - 2024) Analysis & Trends

Johnson & Johnson has disclosed Long-Term Debt Repayments across 16 years of filings, most recently posting $1.0 million for Q1 2024.

  • In Q1 2024, Long-Term Debt Repayments fell 99.8% year-over-year to $1.0 million; the TTM figure through Mar 2024 stood at $1.1 billion (down 68.27% YoY), while the FY2025 annual figure was $1.8 billion, up 20.92% from the prior year.
  • Long-Term Debt Repayments came in at $1.0 million for Q1 2024 at Johnson & Johnson, down from $1.0 billion in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $2.1 billion in Q2 2022 to a low of $1.0 million in Q4 2021.
  • Average Long-Term Debt Repayments over 5 years is $529.4 million, with a median of $500.0 million recorded in 2023.
  • Year-over-year, Long-Term Debt Repayments surged 18266.67% in 2020 and sank 99.82% in 2021.
  • Over 5 years, Long-Term Debt Repayments stood at $551.0 million in 2020, then slumped by 99.82% to $1.0 million in 2021, then soared by 213100.0% to $2.1 billion in 2022, then tumbled by 50.8% to $1.0 billion in 2023, then slumped by 99.9% to $1.0 million in 2024.
  • Per Business Quant data, the three most recent Long-Term Debt Repayments figures were $1.0 million in Q1 2024, $1.0 billion in Q4 2023, and $1.0 million in Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Repayments (Qtr)
1 Johnson & Johnson 663.08 Bn 642.33 Bn 17.26 Bn -
2 AbbVie 453.04 Bn 446.51 Bn 12.70 Bn 2.00 Bn
3 Merck 370.87 Bn 363.78 Bn 12.21 Bn 5.00 Mn
4 Novartis Ag 305.29 Bn 298.00 Bn 11.24 Bn -
5 Pfizer 162.10 Bn 150.70 Bn 10.94 Bn -
6 Sanofi 53.95 Bn 46.98 Bn 10.79 Bn -
7 Revolution Medicines 45.00 Bn 45.00 Bn - -
8 BeOne Medicines 40.49 Bn 35.39 Bn 1.53 Bn 17.05 Mn
9 Incyte 25.47 Bn 20.94 Bn 1.57 Bn -
10 United Therapeutics 20.81 Bn 18.15 Bn 683.80 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 1.00 Mn
Dec 31, 2023 1.05 Bn
Oct 1, 2023 1.00 Mn
Jul 2, 2023 1.00 Mn
Apr 2, 2023 500.00 Mn
Jan 1, 2023 682.00 Mn
Apr 3, 2022 2.13 Bn
Oct 3, 2021 1.00 Mn
Jul 4, 2021 450.00 Mn
Apr 4, 2021 1.00 Bn
Jan 3, 2021 502.00 Mn
Sep 27, 2020 551.00 Mn
Mar 29, 2020 11.00 Mn
Dec 29, 2019 1.82 Bn
Sep 29, 2019 3.00 Mn
Jun 30, 2019 3.00 Mn
Mar 31, 2019 1.00 Bn
Dec 30, 2018 645.00 Mn
Sep 30, 2018 901.00 Mn
Jul 1, 2018 1.00 Mn